Overall, this study capitalized on the largest cohort of adults with DS with clinical assessments and multimodal biomarkers to inform on the age-related association of the APOE ɛ4 allele with in vivo AD biomarkers, increasing the understanding of the mechanisms that link APOE to the acceleration of disease in genetically at-risk populations. The gene discussed is APOE; the disease is Alzheimer disease.